Unlocking the Power of Postbiotics — From Promise to Proof
Unlocking the Power of Postbiotics — From Promise to Proof
Jan 15, 2026
Jan 15, 2026
Jan 15, 2026




Event Overview:
Postbiotics represent a rapidly evolving category within gut health innovation. However, regulatory acceptance depends on robust scientific substantiation aligned with EFSA requirements. This session focuses on translating postbiotic science into regulatory-ready evidence that supports compliant positioning in the EU and UK.
Event Overview:
Postbiotics represent a rapidly evolving category within gut health innovation. However, regulatory acceptance depends on robust scientific substantiation aligned with EFSA requirements. This session focuses on translating postbiotic science into regulatory-ready evidence that supports compliant positioning in the EU and UK.
Event Overview:
Postbiotics represent a rapidly evolving category within gut health innovation. However, regulatory acceptance depends on robust scientific substantiation aligned with EFSA requirements. This session focuses on translating postbiotic science into regulatory-ready evidence that supports compliant positioning in the EU and UK.
Key Discussion Points
Key Discussion Points
Postbiotics definition: scientific and regulatory perspectives
Evidence generation aligned with EFSA expectations
Characterization and mechanism of action requirements
Characterization and mechanism of action requirements
Regulatory challenges in biotics innovation
Speakers
Speakers




Dr. Sandra Einerhand
Dr. Sandra Einerhand
Dr. Sandra Einerhand
Dr. Sandra Einerhand is a leading authority in microbiome science and regulatory strategy, with extensive experience guiding companies on evidence generation for EFSA submissions. She has supported multiple biotics-related regulatory dossiers and scientific evaluations across EU markets.
Dr. Sandra Einerhand is a leading authority in microbiome science and regulatory strategy, with extensive experience guiding companies on evidence generation for EFSA submissions. She has supported multiple biotics-related regulatory dossiers and scientific evaluations across EU markets.
Dr. Sandra Einerhand is a leading authority in microbiome science and regulatory strategy, with extensive experience guiding companies on evidence generation for EFSA submissions. She has supported multiple biotics-related regulatory dossiers and scientific evaluations across EU markets.
Related Webinars
Related Webinars

Health Claims in the EU & UK – Challenges & Opportunities
Feb 13, 2026

Unlocking the Power of Postbiotics — From Promise to Proof
Jan 15, 2026

Novel Foods in the EU & UK: Challenges & Opportunities
Dec 4, 2025

Vedic Lifesciences — Where Innovation Meets Evidence
Clinical trials, regulatory clarity and brand growth for global health innovators.
Explore Now
Vedic lifesciences scoops Nutra
Ingredients research project award.
© 2025 Vedic Lifescience Pvr Ltd. All Rights Reserved.
Designed and Developed with ❤️ at Codesis

Vedic Lifesciences — Where Innovation Meets Evidence
Clinical trials, regulatory clarity and brand growth for global health innovators.
Explore Now
Vedic lifesciences scoops Nutra
Ingredients research project award.
© 2025 Vedic Lifescience Pvr Ltd. All Rights Reserved.
Designed and Developed with ❤️ at Codesis

Vedic Lifesciences — Where Innovation Meets Evidence
Clinical trials, regulatory clarity and brand growth for global health innovators.
Explore Now
Vedic lifesciences scoops Nutra
Ingredients research project award.
© 2025 Vedic Lifescience Pvr Ltd. All Rights Reserved.
Designed and Developed with ❤️ at Codesis
Want to Join Vedic? Reach our HR

Vedic Lifesciences — Where Innovation Meets Evidence
Clinical trials, regulatory clarity and brand growth for global health innovators.
Explore Now
Vedic lifesciences scoops Nutra
Ingredients research project award.
© 2025 Vedic Lifescience Pvr Ltd. All Rights Reserved.
Designed and Developed with ❤️ at Codesis
Want to Join Vedic? Reach our HR

